FindTrial
Sign In

A study comparing to ayurvedic drug Bramhi ghrit and swarnaprashan in growth and development of children

A comparative clinical study of brahmi ghrita swarnaprashan and samvardhan ghrita swarnaprashan in growth and development of children. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/105022
Enrollment
80
Registered
2026-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dr Pavan Govindrao Aaglave
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children between age of 6 months to 16 years. 2.Children of either sex. 3.Children with recurrent episodes of respiratory and gastrointestinal symptoms / diseases.

Exclusion criteria

Exclusion criteria: 1. Known cases of hypersensitivity. 2. Children with autoimmune disorders. 3. Children with metabolic disorders and celiac disease. 4. Children with respiratory and / or gastrointestinal congenital anomalies.

Design outcomes

Primary

MeasureTime frame
Comparative assessment of brahmi ghrita swarnaprashan and samvardhan ghrita swarnaprashan in growth and developement of children.Timepoint: drug administration on every pushya nakshtra ( every 27th day) for 6 months. comparative evaluation at end of 6 months.—

Secondary

MeasureTime frame
To assess whether samvardhan ghrita swarnaprashan is more effective than bramhi ghrita swarnaprashan in growth and development of children.Timepoint: comparative evaluation at the end of 6 months.—

Countries

India

Contacts

Public ContactDr Jayprakash A Khairnar

Ashvin Rural Ayurveda College and Hospital

khairnar.jayaprakash@gmail.com9960610623

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026